Severin Schwan
Executive ChairmanDr. Severin Schwan, Ph.D., serves as Chairman of the Board at Roche Venture Fund. He held this position on 2023. He had been Chief Executive Officer of Roche Holdings, Inc. and Roche Molecular Systems Inc. since March 2008. He was the Executive Chairman of Roche Holding AG from March 14, 2023 and served as its Chief Executive Officer until March 13, 2023. Dr. Schwan has been Group Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2008. He served as the Chief Executive Officer of Roche Diagnostics Corporation from January 1, 2006 to 2008. He served as Chief Executive Officer of Diagnostics Division at Roche Holding AG since January 2006. He served as Trainee of Corporate Finance at Roche Basel from 1993 to 1995, Head Finance & Administration at Roche Brussels from 1995 to 1998, Head Finance & Informatics of Roche Grenzach and Member of the Executive Board of Roche Deutschland Holding GmbH from 1998 to 2000. He was Member of the Board of Credit Suisse AG from 2015 to 2017. He served as Head of Asia Pacific Region, Roche Diagnostics Singapore at Roche Holding AG from 2004 to January 1, 2006. He served as Head of Global Finance & Services of Roche Diagnostics Basel from 2000 to 2004. He serves as a Director of Tusk Therapeutics Ltd. He serves as the Chairman of the Board at Roche Holdings, Inc., since April 29, 2008. He had been Independent Vice-Chair of Credit Suisse Group AG since 2017 until April 29, 2022 and had been its Lead Independent Director since April 28, 2017 until April 29, 2022. He had been an Independent Director of Credit Suisse AG since July 22, 2014 until 2022 and also was its Vice-Chair and Lead Independent Director since 2017 until 2022. He has been Executive Director of Roche Holdings, Inc. since April 29, 2008 and Roche Holding AG/Roche Pharmholding BV. since March 5, 2013. He held various management and other positions at Roche Germany, Belgium and Switzerland from 1993 to 2000. He had been an Independent Director of Credit Suisse Group AG since May 9, 2014 until April 29, 2022. He served as Independent Director at Credit Suisse, Inc. He served as the Chairman at Genentech, Inc. until March 2023 and served as its Director until March 2023. He served as a Member of Scientific Resource Board at Genentech, Inc. He served as Director of Chugai Pharmaceutical Co. Ltd. He is Member of International Business Leaders Advisory Council for the Mayor of Shanghai and Vice-President of International Federation of Pharmaceutical Manufacturers & Associations. Dr. Schwan holds a degree in Economics from University of Innsbruck, University of York and University of Oxford Mag. rer.soc.oec. He received Master's degree in Economics and Law from University of Innsbruck in 1991 and Doctorate in Law from University of Innsbruck Research studies at University Louvain, Belgium.
Positions
- Company NameRoche Holding AGStock CodeRHHBYPositionExecutive ChairmanRelated SecuritiesColleagues
- TSThomas SchineckerGroup Chief Executive Officer
- AHAlan HippeChief Financial Officer
- WMWafaa MamilliChief Digital & Technology Officer
- BEBruno EschliHead of Investor Relations
- ASAndre S. HoffmannIndependent Vice Chairman
- JDJorg DuschmaleNon-Executive Independent Director
- PFPatrick FrostIndependent Non Executive Director
- RPRichard P. LiftonNon-Executive Independent Director
